Anika Therapeutics (ANIK) Tax Rate Growth (1y) (2011 - 2026)
Anika Therapeutics (ANIK) Tax Rate Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Anika Therapeutics | 203.37 Mn | 136.58 Mn | 19.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -229.00 |
| Dec 31, 2025 | 5,550.00 |
| Sep 30, 2025 | -70,794.00 |
| Jun 30, 2025 | 9,149.00 |
| Mar 31, 2025 | -34.00 |
| Dec 31, 2024 | -23,492.00 |
| Sep 30, 2024 | 66,059.00 |
| Jun 30, 2024 | -11,891.00 |
| Mar 31, 2024 | -1,610.00 |
| Dec 31, 2023 | 975.00 |
| Sep 30, 2023 | -1,503.00 |
| Jun 30, 2023 | -368.00 |
| Mar 31, 2023 | -705.00 |
| Dec 31, 2022 | 301.00 |
| Sep 30, 2022 | -3,377.00 |
| Jun 30, 2022 | -1,502.00 |
| Mar 31, 2022 | 15,448.00 |
| Dec 31, 2021 | 5,683.00 |
| Sep 30, 2021 | 3,506.00 |
| Jun 30, 2021 | 787.00 |